How ReCor Medical is building a strong clinical case for renal denervation; let your voice be heard
In this episode, we’ll speak with ReCor Medical’s CEO Andy Weiss and Helen Reeve-Stoffer, PHD, the company’s vice president of clinical affairs. The pair joined the renal denervation company in 2013, before disappointing results of a Medtronic-trial temporarily cratered the entire space. But now through careful clinical testing ReCor Medical is climbing out of that hole and demonstrating the technology could be an effective tool against serious hypertension. To hear the interview we conducted with Andy Weiss in 2021, go here.
Executive Editor Chris Newmarker and Tom Salemi, editorial director of DeviceTalks, begin making plans for next week’s end-of-year coverage. If you want to contribute your insights go here and record your own message for the podcast. https://www.massdevice.com/devicetalks-weekly-whats-your-top-story-of-2022/
Thank you for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network on any podcast application.
Executive Editor Chris Newmarker and Tom Salemi, editorial director of DeviceTalks, begin making plans for next week’s end-of-year coverage. If you want to contribute your insights go here and record your own message for the podcast. https://www.massdevice.com/devicetalks-weekly-whats-your-top-story-of-2022/
Thank you for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network on any podcast application.
Activity